United Health is feeling the burn this week as concerned traders drop shares left and right.
The company saw a big plunge in its share price earlier in the week after suspending its outlook for 2025 and announcing out of nowhere that it would have a new chief executive. On Tuesday United Health said former CEO Stephen Hemsley would replace Andrew Witty, who had been chief since 2021.
Stephen Hemsley hasn’t been CEO at UnitedHealth Group in nearly a decade, but he hasn’t really left the company. He remained a major shareholder in the health care behemoth.
United Health shares continued to fall on Thursday and even reached their lowest levels in five years as another negative headline surfaced about the insurance giant. A new report late Wednesday had revealed that the company is now facing a criminal investigation by the Justice Department related to possible Medicare fraud. The investigation reportedly has been underway since at least last summer.
In a statement issued on Wednesday, UnitedHealth called the story “deeply irresponsible,” referring to a “supposed” investigation. UnitedHealth added in its statement that it stands by the integrity of its Medicare Advantage program.
According to Wall Street analysts, such a surprise change in leadership as well as uncertainty on the company’s 2025 outlook may not bode well with investors until some stability is offered.
Finance’s Anjalee Khemlani noted earlier this week, the company’s challenges are many and include increased costs, scrutiny from the FTC and the Department of Justice as well as political pressure over its size. In a video transcript Khelmani has laid out the timeline of events the health insurer has had to weather in recent times:
It was last year that the company’s former executive Brian Thompson was killed sparking tremendous backlash and fury over the company’s business and claim denials. UnitedHealth’s stock has dragged the Dow into negative territory on many occasions in the last month and shares are down over 50% since mid-April.